Quarterly Report • Oct 30, 2024
Quarterly Report
Open in ViewerOpens in native device viewer
1 January – 30 September 2024 Financial Statements for the Accounting Period
As of 30 September 2024
| (Amounts expressed in Turkish lira ("TL") unless otherwise indicated.) ASSETS |
Notes | 30 September 2024 |
31 December 2023 |
|---|---|---|---|
| Cash and cash equivalents | 3 | 441,553,993 | 955,200,967 |
| Trade receivables | |||
| - Receivables from third parties |
5 | 1,302,912,621 | 609,250,742 |
| Other receivables | |||
| - Receivables from third parties |
7 | 939,013 | 173,939 |
| Inventories | 8 | 589,622,122 | 530,092,243 |
| Prepaid expenses | 9 | 270,685,067 | 49,051,911 |
| Other current assets | 14 | 779,375 | 215,441 |
| Total current assets | 2,606,492,191 | 2,143,985,243 | |
| Other receivables | |||
| - Receivables from third parties |
7 | 8,797 | 8,797 |
| Tangible assets | 10 | 1,886,242,713 | 1,339,431,067 |
| Intangible assets | 11 | 859,206 | 959,753 |
| Prepaid expenses | 9 | - | 114,068 |
| Total non-current assets | 1,887,110,716 | 1,340,513,685 | |
| TOTAL ASSETS | 4,493,602,907 | 3,484,498,928 |
As of 30 September 2024
(Amounts expressed in Turkish lira ("TL") unless otherwise indicated.)
| LIABILITIES | Notes | 30 September 2024 | 31 December 2023 |
|---|---|---|---|
| Current borrowings | 6 | 62,510,564 | 51,425,969 |
| Current portions of non-current borrowings | 6 | 164,310,962 | 466,733,550 |
| Current leasing borrowings | 6 | 82,809,272 | 24,323,650 |
| Other financial liabilities | 6 | 2,285,674 | 1,021,527 |
| Trade payables | |||
| - Payables to third parties | 5 | 598,387,106 | 183,978,717 |
| Other payables | |||
| - Payables to third parties | 7 | 1,594,762 | 755,488 |
| Payables for employee benefits | 13 | 11,706,769 | 10,002,969 |
| Deferred income | 9 | 76,787,820 | 306,249,574 |
| Current provisions | |||
| - Current provisions for employee benefits | 13 | 4,954,857 | 3,623,052 |
| - Other current provisions | 13 | 3,388,177 | 4,795,029 |
| Other Current liabilities | 14 | 10,211,500 | 10,259,855 |
| Total current liabilities | 1,018,947,463 | 1,063,169,380 | |
| Non-current borrowings | 6 | 4,045,385 | 46,352,296 |
| Non-current leasing borrowings | 6 | 340,071,281 | 52,694,154 |
| Trade payables | |||
| -Payables to third parties | 5 | 447,150,780 | - |
| Non-current provisions | |||
| - Non-Current provisions for employee benefits | 13 | 3,212,664 | 2,685,098 |
| Deferred tax liability | 23 | 2,516,570 | 46,244,083 |
| Total non-current liabilities | 796,996,680 | 147,975,631 | |
| Paid-in capital | 15 | 100,000,000 | 80,000,000 |
| Positive distinction from share capital adjustment | 15 | 295,028,852 | 292,628,451 |
| Premiums (discounts) related to shares | 15 | 902,623,746 | 902,623,746 |
| Other refills | 15 | - | 27,172,068 |
| Other Accumulated Comprehensive Income and Expenses Not to be Reclassified to Profit and Loss |
|||
| - Fixed assets revaluation increases/decreases | 15 | 297,579,220 | 297,579,220 |
| - Remeasurement gains/losses of defined benefit | |||
| plans | 15 | (3,317,364) | (1,278,430) |
| Restricted reserves separated from profit | 15 | 17,983,290 | 6,707,444 |
| Previous years' profits | 661,417,239 | 370,084,456 | |
| Net profit for the period | 406,343,781 | 297,836,962 | |
| EQUITY | 2,677,658,764 | 2,273,353,917 | |
| TOTAL LIABILITIES | 4,493,602,907 | 3,484,498,928 |
(Amounts expressed in Turkish lira ("TL") unless otherwise indicated.)
| 1 January – | 1 January – | 1 July- | 1 July | ||
|---|---|---|---|---|---|
| Notes | 30 September 2024 | 30 September 2023 | 30 September 2024 | 30 September 2023 | |
| Revenues | 16 | 3,300,967,955 | 1,839,436,025 | 1,105,233,430 | 751,193,104 |
| Cost of sales (-) | 16 | (2,463,977,264) | (1,414,007,569) | (831,806,759) | (585,932,647) |
| Gross profit | 836,990,691 | 425,428,456 | 273,426,671 | 165,260,457 | |
| General and administrative expenses (-) | 17 | (71,797,367) | (54,368,129) | (20,041,103) | (4,364,819) |
| Marketing, sales, and distribution expenses (-) | 18 | (220,546,172) | (100,243,810) | (63,367,593) | (40,741,905) |
| Research and development expenses (-) | 19 | (3,653,793) | - | (3,585,174) | - |
| Other income from main operations | 20 | 31,519,770 | 14,419,313 | 5,223,071 | 4,428,693 |
| Other operating expenses (-) | 20 | (79,477,583) | (23,315,707) | (50,588,179) | (2,913,191) |
| Operating profit | 493,035,546 | 261,920,123 | 141,067,693 | 121,669,235 | |
| Expenses from investment activities (-) | 21 | 1,334,986 | 2,298,207 | 666,667 | 1,526,252 |
| Operating profit before financing expense | 494,370,532 | 264,218,330 | 141,734,360 | 123,195,487 | |
| Financing revenues | 22 | 190,354,288 | 2,648,996 | 56,758,710 | 770,984 |
| Financial expenses (-) | 22 | (107,317,950) | (101,849,207) | (35,438,764) | (23,284,437) |
| Net monetary (loss) / gain | (156,575,655) | 99,244,181 | (36,321,987) | (20,956,626) | |
| Profit before tax | 420,831,215 | 264,262,300 | 126,732,319 | 79,725,408 | |
| Period tax expense | 23 | (11,636,488) | (7,337,299) | (4,332,351) | 1,842,754 |
| Deferred tax (expense) | 23 | (2,850,946) | (70,137,999) | (96,123,810) | (53,635,967) |
| Period profit | 406,343,781 | 186,787,002 | 26,276,158 | 27,932,195 | |
| OTHER COMPREHENSIVE INCOME | (2,038,934) | (286,353) | (5,115,984) | (1,268,713) | |
| Items that will not be reclassified | |||||
| subsequently to profit or loss: | |||||
| Gains on remeasurement of defined benefit | |||||
| plans | 13 | (2,647,966) | (357,941) | (6,644,135) | (1,585,891) |
| Deferred tax revenue | 609,032 | 71,588 | 1,528,151 | 317,178 | |
| TOTAL COMPREHENSIVE INCOME | 404,304,847 | 186,500,649 | 21,160,174 | 26,663,482 |
(Amounts expressed in Turkish lira ("TL") unless otherwise indicated.)
| Other accumulated comprehensive income or expenses that will not be reclassified to profit or loss |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Paid in capital |
Positive distinction from share capital adjustment |
Premiums (discounts) related to shares |
Other reserves |
Restricted reserves separated from profit |
Fixed assets revaluation increases |
Defined benefit plan remeasurement differences |
Previous years' profits |
Net profit/ (loss) for the period |
Equity total | |
| 1 January 2023 | 60,000,000 | 270,647,528 | - | - | 1,406,213 | 58,994,073 | (828,740) | 122,482,328 | 274,441,714 | 787,143,116 |
| Transfers | 20,000,000 | 22,219,429 | - | - | 8,190,416 | - | - | 224,031,869 | (274,441,714) | - |
| Other comprehensive income/expense |
- | - | - | - | - | - | (286,353) | - | - | (286,353) |
| Net profit for the period |
- | - | - | - | - | - | - | - | 186,787,002 | 186,787,002 |
| 30 September 2023 | 80,000,000 | 292,866,957 | - | - | 9,596,629 | 58,994,073 | (1,115,093) | 346,514,197 | 186,787,002 | 973,643,765 |
| 1 January 2024 | 80,000,000 | 292,628,451 | 902,623,746 | 27,172,068 | 6,707,444 | 297,579,220 | (1,278,430) | 370,084,456 | 297,836,962 | 2,273,353,917 |
| Transfers | 20,000,000 | 2,400,401 | - | (27,172,068) | 11,275,846 | - | - | 291,332,783 | (297,836,962) | - |
| Other comprehensive income/expense |
- | - | - | - | - | - | (2,038,934) | - | - | (2,038,934) |
| Net profit for the period |
- | - | - | - | - | - | - | - | 406,343,781 | 406,343,781 |
| 30 September 2024 | 100,000,000 | 295,028,852 | 902,623,746 | - | 17,983,290 | 297,579,220 | (3,317,364) | 661,417,239 | 406,343,781 | 2,677,658,764 |
(Amounts expressed in Turkish lira ("TL") unless otherwise indicated.)
| 1 January – | 1 January – | ||
|---|---|---|---|
| Notes | 30 September 2024 | 30 September 2023 | |
| A, CASH FLOWS FROM BUSINESS ACTIVITIES Profit for the Period |
|||
| Adjustments to Reconcile Profit for the Period | 406,343,781 | 186,787,002 | |
| Adjustments for depreciation and amortization | 10,11 | 59,341,421 | 46,014,629 |
| Corrections regarding lawsuit provisions | 13 | (141,204) | 2,422,653 |
| Fixes regarding leave provisions | 13 | 2,288,110 | 2,643,556 |
| Adjustments for unrealized foreign currency translation differences | 41,197,941 | 22,254,066 | |
| Adjustments regarding interest income | 21 | (187,711,695) | (1,886,519) |
| Adjustments regarding severance pay expense | 13 | 2,235,471 | 4,641,990 |
| Adjustments for impairment of trade and other receivables | - | 103,386 | |
| Net monetary loss/gain | (232,767,599) | (185,043,898) | |
| Adjustments regarding tax expense/income | 23 | (43,118,481) | 82,668,031 |
| Operating Profit Before Changes in Working Capital | 47,667,745 | 160,604,896 | |
| Adjustments regarding increase/decrease in trade receivables | (693,661,879) | (127,059,708) | |
| Adjustments related to increase/decrease in stocks | (59,529,879) | (144,900,026) | |
| Adjustments for increases/decreases in other receivables related to activities Adjustments for increases/decreases in prepaid expenses |
(765,074) (221,519,088) |
(1,536,426) (52,762,474) |
|
| Adjustments for increases/decreases in other assets | (563,934) | 257,615 | |
| Adjustments regarding increase/decrease in commercial payables | 861,559,169 | 147,624,049 | |
| Adjustments for increases/decreases in other payables related to operations | 839,274 | 2,125,728 | |
| Adjustments related to increase/decrease in deferred revenues | (229,461,754) | (57,829,442) | |
| Adjustments for increases/decreases in other liabilities | (48,355) | (24,712,896) | |
| Adjustments regarding increases/decreases in employee benefits | 1,703,800 | 7,296,869 | |
| Interest received | 22 | 188,298,345 | 2,063,914 |
| Severance pay paid | 13 | (3,647,139) | (1,615,334) |
| Cash Flows from Operations | (109,128,769) | (90,443,235) | |
| B, CASH FLOWS FROM INVESTING ACTIVITIES | |||
| Cash outflows from the sale of tangible and intangible assets | 10,11 | (606,308,931) | (179,707,421) |
| Cash inflows from the sale of tangible and intangible assets | 10,11 | 256,411 | 61,638 |
| Cash Flows from Investment Activities | (606,052,520) | (179,645,783) | |
| C, CASH FLOWS FROM FINANCE ACTIVITIES | |||
| Cash inflows/outflows arising from other receivables from related | |||
| parties/other payables to related parties | |||
| Cash inflows from financial borrowings | 6 | 758,466,232 | 756,860,531 |
| Change in financial assets | - | (5,719,001) | |
| Interest paid | 22 | (51,812,194) | (65,270,055) |
| Cash outflows related to debt payments | (505,119,723) | (425,734,334) | |
| Cash flows from financing activities | 201,534,315 | 260,137,141 | |
| NET INCREASE/(DECREASE) IN CASH AND CASH EQUIVALENTS | |||
| (A+B+C) | (513,646,974) | (9,951,877) | |
| D, CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD |
955,200,967 | 33,196,993 | |
| Balance at the end of the period | 3 | 441,553,993 | 23,245,116 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.